BIOE
Bio Essence Corp
Key Financials
Revenue
$1.9M
↑ 485.8%
Operating Income
$900011
↑ 295.9%
Net Income
$896197
↑ 168.5%
EPS (Diluted)
$-0.03
↓ 50.0%
Gross Profit
$1.4M
↑ 558.0%
Cash & Equivalents
$1371.00
↑ 1102.6%
Total Liabilities
$2.5M
↓ 23.2%
Total Assets
$422474.00
↑ 50.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 8-K/A | 5/19/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 4/24/2026 | View on SEC |
| 10-K | 3/27/2026 | View on SEC |
| QUALIF | 1/5/2026 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 1-A | 10/17/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 10-Q | 5/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIOE |
| Company Name | Bio Essence Corp |
| CIK | 1723059 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | CA |
| Phone | 888-816-1494 |